Generic Strattera (Atomoxetine)

Common Use
Strattera contains atomoxetine hydrochloride, a selective norepinephrine reuptake inhibitor (NRI) used to treat Attention Deficit Hyperactivity Disorder (ADHD). It works by increasing norepinephrine levels in the brain to help improve focus and reduce impulsiveness and hyperactivity.
Symptoms addressed by Strattera include:

• Lack of concentration

• Distractibility

• Impulsiveness

• Disorganization

• Restlessness

Dosage and Administration

• Take Strattera once or twice daily, with or without food.

• Do not open, crush, or sprinkle the capsule on food — swallow whole.

• Strattera does not require tapering when discontinuing.

• Initial dose (for patients >70 kg): 40 mg/day

• May increase to 80 mg/day after 3 days

• Maximum dose: 120 mg/day (not to be reached earlier than 2–4 weeks after starting treatment)

• Always follow your doctor’s exact instructions.

Precautions
Inform your doctor if you have or had:

• Heart conditions (e.g., congenital defects, coronary artery disease, recent heart attack, rhythm disturbances)

• Hypertension or hypotension

• Cerebrovascular disorders

• Liver disease or urinary problems

• Mental health issues (e.g., bipolar disorder, depression, psychosis, suicidal ideation)

• Use during pregnancy is advised only if benefits outweigh potential risks.

Contraindications
Do not take Strattera if you:

• Are currently or were recently (within 14 days) treated with MAO inhibitors (e.g., phenelzine, tranylcypromine, moclobemide)

• Have angle-closure glaucoma

• Are allergic to atomoxetine or any of the inactive ingredients

Possible Side Effects

Common side effects may include:

• Dry mouth

• Nausea, vomiting, stomach upset

• Decreased appetite

• Dizziness, tiredness

• Insomnia

• Sexual dysfunction

Serious side effects (seek immediate help if any occur):

• Chest pain, irregular heartbeat, shortness of breath

• Fainting, lightheadedness

• Liver problems (e.g., dark urine, clay-colored stools, yellowing of skin/eyes)

• Urinary retention or difficulty

• Mood changes, suicidal thoughts

Drug Interactions
Strattera should not be used with MAO inhibitors or within 14 days of stopping MAOIs.
Strattera levels may be increased by medications that inhibit the enzyme CYP2D6, including:

• Fluoxetine (Prozac)

• Paroxetine (Paxil)

• Quinidine
  Other possible interactions include:

• Albuterol, bupropion, cimetidine, methadone, celecoxib, ritonavir, theophylline, metoclopramide, amiodarone, ranitidine, terbinafine, and chemotherapy agents like doxorubicin
  Always inform your doctor of all medications, supplements, and herbal products you use.

Missed Dose

• If you miss a dose, take it as soon as you remember.

• If it’s close to your next dose, skip the missed dose.

• Do not double the dose to make up for a missed one.

Overdose
Symptoms may include:

• Tachycardia (fast heart rate)

• Dry mouth, agitation, hyperactivity

• Drowsiness, blurred vision, mydriasis (dilated pupils)

• Stomach upset, behavioral disturbances
  Seek immediate medical attention if an overdose is suspected.

Storage

• Store at room temperature: 20–25°C (68–77°F)

• Keep away from heat, light, and moisture

• Do not store in bathrooms

• Keep out of reach of children and pets

Disclaimer
This information is for general educational purposes only and does not substitute professional medical advice. Always consult a licensed healthcare provider for diagnosis, treatment, and individualized medical recommendations. We disclaim responsibility for any adverse effects resulting from the misuse or misinterpretation of this information.